Skip to content
★ Sign in to follow
SWS Hemodialysis Care Co., Ltd. logo

SWS Hemodialysis Care Co., Ltd. Stock: price and insider trades · China

山外山

CN·Mcap CN¥4BHealth Care

No insider purchase over the last 90 days. The latest, by 高光勇, was filed 07 Jul 2023.

SWS Hemodialysis Care Co., Ltd.: what insiders have been doing

This page follows insider dealings at SWS Hemodialysis Care Co., Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. Between 6 November 2025 and 6 November 2026, 1 insider published 1 filing.

The flow runs one way only: 1 sale worth €2.3M, from 1 insider, and no purchase. One trade stands out by size: a sale of €2.3M from 高光勇, disclosed on 18 June 2026.

With 1 filing in twelve months, the company is quieter than the median of 2 filings across the 514 companies we follow on the same exchange. Since 2023, the database holds 1 purchase and 1 sale by insiders of the company.

A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.

Insider Decl.
2
Thresholds
n/a
Buy Volume
€31,306
1 ops. · all time
Sell Volume
€2M
1 ops. · all time

Who traded when

BuySale
高光勇1 sale

Since the insiders bought

  • Filed 07 Jul 2023 · 1220 days ago · €31k
    -49.0%
    Entry CN¥22.47 · Close at T+365 CN¥11.45

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 7,689 of 26,912 companies
62.3
score / 100
Value
45
Quality
80
FCF yld3.8%
Earn yld3.7%
EV/EBITDA21.1x
ROE10%
Gross mgn50%
Net mgn18%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥8.83
Analyst consensus
1 analysts
·
CN¥15.00Target CN¥15.00(+70%)CN¥15.00
Income statement
RevenueCN¥806.9M
Gross profitCN¥405.3M50% margin
EBITDACN¥187.4M23% margin
Net incomeCN¥145.9M20.3% margin
Valuation
PER (trailing)17.7x
P/Book2.2x
Beta0.50
Balance sheet & cash
Market capCN¥4B
Total debtCN¥2.1M
Free Cash FlowCN¥151.9M
Debt / Equity0%
Profitability & ownership
ROE10.5%
ROA5.6%
% insiders42.0%
% institutions18.2%
Last declaration on 18 June 2026
Declarations2 total
  • ▼
    董事,高级管理人员,核心技术人员Executives
    18M CNY15SSE
    1,242,924 shares@ CN¥113.006598.7% of flowA股XSHGSSE:273000000750335260
  • ▲
    董事,高级管理人员,核心技术人员Executives
    247,520 CNY7SSE
    4,760 shares1.3% of flowA股XSHGSSE:173000006722302620
    Canonical exit: 5 Oct 2023 (T+90)

2 of 2 declarations

About SWS Hemodialysis Care Co., Ltd.

山外山 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on the development and distribution of pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations